Jounce Therapeutics is dedicated to transforming the treatment of cancer. The company is discovering and developing first-in-class cancer immunotherapies designed to harness the immune system to seek out and attack cancerous cells and tumors. Jounceâ??s proprietary product engine is driving this transformational approach, which has the potential to drive significantly more durable responses to treatment, extending and improving patientsâ?? quality of life. Founded by world leaders in immunobiology, cancer biology and clinical and translational medicine, Jounce Therapeutics was launched in 2013 with funding from leading life sciences investor, Third Rock Ventures.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Jounce Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Jounce Therapeutics Inc market cap is $98.95M.
What is the 52-week high for Jounce Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Jounce Therapeutics Inc 52 week high is $5.87 as of October 03, 2025.
What is the 52-week low for Jounce Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Jounce Therapeutics Inc 52 week low is $0.5773 as of October 03, 2025.
What is Jounce Therapeutics Inc stock price today?
Jounce Therapeutics Inc stock price today is $1.88.
What was Jounce Therapeutics Inc stock price yesterday?
Jounce Therapeutics Inc stock price yesterday was $1.93.
What is the PE ratio of Jounce Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Jounce Therapeutics Inc’s P/E ratio is -1.91.
What is the Price-to-Book ratio of Jounce Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Jounce Therapeutics Inc P/B ratio is 0.5307.
What is the 50-day moving average of Jounce Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Jounce Therapeutics Inc 50-day moving average is $1.61.